Norbert W. Bischofberger

2008

In 2008, Norbert W. Bischofberger earned a total compensation of $4.4M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 5% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$495,180
Option Awards$2,649,403
Salary$653,798
Stock Awards$587,263
Other$5,350
Total$4,390,994

Bischofberger received $2.6M in option awards, accounting for 60% of the total pay in 2008.

Bischofberger also received $495.2K in non-equity incentive plan, $653.8K in salary, $587.3K in stock awards and $5.4K in other compensation.

Rankings

In 2008, Norbert W. Bischofberger's compensation ranked 973rd out of 9,135 executives tracked by ExecPay. In other words, Bischofberger earned more than 89.3% of executives.

ClassificationRankingPercentile
All
973
out of 9,135
89th
Division
Manufacturing
348
out of 3,436
90th
Major group
Chemicals And Allied Products
67
out of 815
92nd
Industry group
Drugs
41
out of 597
93rd
Industry
Biological Products, Except Diagnostic Substances
5
out of 118
96th
Source: SEC filing on March 12, 2009.

Bischofberger's colleagues

We found six more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2008.

2008

John Martin

Gilead Sciences

Chief Executive Officer

2008

John Milligan

Gilead Sciences

Chief Operating Officer

2008

Kevin Young

Gilead Sciences

Executive Vice President, Commercial Operations

2008

Robin Washington

Gilead Sciences

Chief Financial Officer

2008

Gregg Alton

Gilead Sciences

Executive Vice President, Corporate and Medical Affairs

2008

Caroline Dorsa

Gilead Sciences

Chief Financial Officer

In-depth

You may also like